[Recent advances in diagnosis of pancreatic cancer].
The clinical course of patients with pancreatic cancer remains dismal. This may be because the pancreas is a retroperitoneal organ, the symptoms are non-specific, occur late, and pancreas cancer has an invasive nature. Screening for asymptomatic or symptomatic patients using serum tumor markers and ultrasonography is not cost-effective. However, the clinical course of small carcinomas less than 1 cm or 1 cm in size is favorable. Thus, the detection of small pancreatic carcinoma is essential to improve the clinical outcome. Possible discovery of pancreatic carcinoma as a diagnostic clue to diabetes mellitus, and intraductal papillary-mucinous neoplasm are introduced based on our clinical experience.
Yamaguchi
Koji
K
Dept. of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ogawa
Yoshiaki
Y
Yokohata
Kazuki
K
Konomi
Hiroyuki
H
Nakamura
Masafumi
M
Nagata
Shigenori
S
Tanaka
Masao
M
D002288:Adenocarcinoma, Mucinous / Q000175:diagnosis; D000231:Adenocarcinoma, Papillary / Q000175:diagnosis; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D021441:Carcinoma, Pancreatic Ductal / Q000175:diagnosis; D002760:Cholangiopancreatography, Endoscopic Retrograde; D003920:Diabetes Mellitus / Q000175:diagnosis; D005260:Female; D006801:Humans; D008297:Male; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000473:pathology; D011379:Prognosis
D014408:Biomarkers, Tumor